PDB Short entry for 2C6F HEADER HYDROLASE 09-NOV-05 2C6F TITLE STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN CAVEAT 2C6F ILE B 79 HAS WRONG CHIRALITY AT ATOM CA LEU B 410 HAS WRONG CAVEAT 2 2C6F CHIRALITY AT ATOM CA ILE B 530 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 2C6F CB COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N DOMAIN, RESIDUES 30-641; COMPND 5 SYNONYM: SOMATIC ANGIOTENSIN-I CONVERTING ENZYME N DOMAIN, DIPEPTIDYL COMPND 6 CARBOXYPEPTIDASE I, KININASE II, CD143 ANTIGEN; COMPND 7 EC: 3.4.15.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: CHO-K1; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PEE14 KEYWDS HYDROLASE, ANGIOTENSIN-I CONVERTING ENZYME, N DOMAIN, ZINC KEYWDS 2 METALLOPEPTIDASE, METALLOPROTEASE, ANGIOTENSIN, LISINOPRIL, KEYWDS 3 ALTERNATIVE SPLICING, CARBOXYPEPTIDASE, GLYCOPROTEIN, METAL-BINDING, KEYWDS 4 PHOSPHORYLATION, PROTEASE, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR H.R.CORRADI,S.L.U.SCHWAGER,A.NICHINDA,E.D.STURROCK,K.R.ACHARYA REVDAT 4 13-DEC-23 2C6F 1 REMARK HETSYN REVDAT 3 29-JUL-20 2C6F 1 CAVEAT COMPND REMARK HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 24-FEB-09 2C6F 1 VERSN REVDAT 1 08-NOV-06 2C6F 0 JRNL AUTH H.R.CORRADI,S.L.U.SCHWAGER,A.T.NCHINDA,E.D.STURROCK, JRNL AUTH 2 K.R.ACHARYA JRNL TITL CRYSTAL STRUCTURE OF THE N DOMAIN OF HUMAN SOMATIC JRNL TITL 2 ANGIOTENSIN I-CONVERTING ENZYME PROVIDES A STRUCTURAL BASIS JRNL TITL 3 FOR DOMAIN-SPECIFIC INHIBITOR DESIGN. JRNL REF J.MOL.BIOL. V. 357 964 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16476442 JRNL DOI 10.1016/J.JMB.2006.01.048 REMARK 2 REMARK 2 RESOLUTION. 3.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1705344.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 35643 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1441 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5410 REMARK 3 BIN R VALUE (WORKING SET) : 0.3180 REMARK 3 BIN FREE R VALUE : 0.4080 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 237 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9736 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 210 REMARK 3 SOLVENT ATOMS : 24 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : 0.49 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.47 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.64 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.560 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 25.64 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2C6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1290026315. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAY-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.90 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36858 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 48.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1O8A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M LITHIUM SULPHATE, 0.1M SODIUM REMARK 280 ACETATE, PH 4.9, 10UM ZINC SULPHATE, 15% POLYETHYLENE GLYCOL REMARK 280 4000, PH 4.90 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.63500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 85.63500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 50.56000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 105.66000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 50.56000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 105.66000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 85.63500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 50.56000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 105.66000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 85.63500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 50.56000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 105.66000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU B 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 1 CG CD1 CD2 REMARK 470 GLN A 22 CG CD OE1 NE2 REMARK 470 SER A 26 OG REMARK 470 GLU A 56 CG CD OE1 OE2 REMARK 470 GLN A 70 CG CD OE1 NE2 REMARK 470 GLU A 74 CG CD OE1 OE2 REMARK 470 ASN A 131 CG OD1 ND2 REMARK 470 LYS A 132 CG CD CE NZ REMARK 470 THR A 133 OG1 CG2 REMARK 470 THR A 135 OG1 CG2 REMARK 470 ASP A 140 CG OD1 OD2 REMARK 470 GLN A 188 CG CD OE1 NE2 REMARK 470 ARG A 240 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 273 CG OD1 OD2 REMARK 470 ASP A 278 CG OD1 OD2 REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 GLU A 315 CG CD OE1 OE2 REMARK 470 ASP A 324 CG OD1 OD2 REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 LYS A 407 CG CD CE NZ REMARK 470 ASP A 412 CG OD1 OD2 REMARK 470 ARG A 413 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 414 CG1 CG2 REMARK 470 THR A 415 OG1 CG2 REMARK 470 ASN A 416 CG OD1 ND2 REMARK 470 LYS A 535 CG CD CE NZ REMARK 470 LYS A 542 CG CD CE NZ REMARK 470 GLU A 609 CG CD OE1 OE2 REMARK 470 ILE A 611 CG1 CG2 CD1 REMARK 470 ASP A 612 CG OD1 OD2 REMARK 470 ASP B 2 CG OD1 OD2 REMARK 470 ASN B 9 CG OD1 ND2 REMARK 470 SER B 11 OG REMARK 470 ASP B 13 CG OD1 OD2 REMARK 470 LEU B 19 CG CD1 CD2 REMARK 470 GLN B 22 CG CD OE1 NE2 REMARK 470 SER B 23 OG REMARK 470 GLN B 34 CG CD OE1 NE2 REMARK 470 ARG B 52 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 53 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 56 CG CD OE1 OE2 REMARK 470 GLN B 70 CG CD OE1 NE2 REMARK 470 GLU B 74 CG CD OE1 OE2 REMARK 470 ILE B 79 CG1 CG2 CD1 REMARK 470 THR B 84 OG1 CG2 REMARK 470 ARG B 90 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 132 CG CD CE NZ REMARK 470 THR B 133 OG1 CG2 REMARK 470 THR B 135 OG1 CG2 REMARK 470 ASN B 276 CG OD1 ND2 REMARK 470 LEU B 277 CG CD1 CD2 REMARK 470 ASP B 278 CG OD1 OD2 REMARK 470 GLU B 315 CG CD OE1 OE2 REMARK 470 LYS B 341 CG CD CE NZ REMARK 470 ARG B 350 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 403 CG CD OE1 OE2 REMARK 470 LEU B 410 CG CD1 CD2 REMARK 470 ASP B 412 CG OD1 OD2 REMARK 470 ARG B 413 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 ILE B 530 CD1 REMARK 470 LYS B 535 CG CD CE NZ REMARK 470 GLN B 568 CG CD OE1 NE2 REMARK 470 GLU B 609 CG CD OE1 OE2 REMARK 470 ILE B 611 CG1 CG2 CD1 REMARK 470 ASP B 612 CG OD1 OD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ILE A 92 CD1 REMARK 480 LYS A 126 CD CE NZ REMARK 480 LYS A 274 CE NZ REMARK 480 GLU B 77 CD OE1 OE2 REMARK 480 LYS B 126 CD CE REMARK 480 LYS B 274 CD CE NZ REMARK 480 GLN B 285 CD OE1 NE2 REMARK 480 ILE B 408 CD1 REMARK 480 LYS B 542 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O4 NAG C 1 C2 NAG C 2 2.02 REMARK 500 CD PRO B 3 NE2 GLN B 6 2.13 REMARK 500 CG2 THR B 282 CB LEU B 410 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 3 CA - N - CD ANGL. DEV. = -31.9 DEGREES REMARK 500 TYR B 607 CB - CG - CD2 ANGL. DEV. = 4.5 DEGREES REMARK 500 TYR B 607 CB - CG - CD1 ANGL. DEV. = -6.0 DEGREES REMARK 500 PRO B 608 CA - N - CD ANGL. DEV. = -26.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 7 -84.74 -42.34 REMARK 500 ASN A 9 135.60 -173.83 REMARK 500 ALA A 12 36.25 -77.00 REMARK 500 ASN A 45 116.38 -173.45 REMARK 500 GLN A 81 -1.63 84.21 REMARK 500 TYR A 111 -73.46 -46.97 REMARK 500 PRO A 130 -70.90 -46.12 REMARK 500 THR A 135 120.36 -28.73 REMARK 500 ASN A 203 71.34 42.98 REMARK 500 ALA A 250 -10.86 -44.58 REMARK 500 MET A 256 -32.54 -38.83 REMARK 500 VAL A 269 118.00 -39.87 REMARK 500 PRO A 272 -165.16 -77.12 REMARK 500 LEU A 277 37.82 -86.71 REMARK 500 THR A 280 -28.67 -35.48 REMARK 500 PRO A 322 171.00 -50.25 REMARK 500 ARG A 340 8.58 52.42 REMARK 500 LYS A 341 -51.73 -122.35 REMARK 500 VAL A 351 85.97 -62.12 REMARK 500 ASP A 374 45.14 -97.40 REMARK 500 ILE A 391 -53.02 -29.81 REMARK 500 ARG A 413 -161.74 -128.96 REMARK 500 VAL A 414 101.45 -161.33 REMARK 500 PHE A 484 66.48 -152.08 REMARK 500 PHE A 490 -34.17 -36.87 REMARK 500 VAL A 495 68.66 30.91 REMARK 500 ILE A 499 -5.23 -53.14 REMARK 500 ARG A 532 17.16 51.13 REMARK 500 GLN A 545 4.17 -56.37 REMARK 500 GLU A 596 48.40 -89.86 REMARK 500 GLN A 598 -11.33 83.68 REMARK 500 PRO A 608 56.05 -141.55 REMARK 500 PRO B 3 -81.21 82.90 REMARK 500 LEU B 5 9.37 -69.87 REMARK 500 ALA B 12 71.74 -101.35 REMARK 500 ASP B 13 -162.00 -126.67 REMARK 500 ASN B 45 88.88 -166.61 REMARK 500 THR B 47 -151.88 -123.36 REMARK 500 ILE B 79 -139.14 -119.95 REMARK 500 TRP B 80 -50.32 73.45 REMARK 500 PRO B 130 -6.61 -40.96 REMARK 500 ALA B 134 117.74 -8.89 REMARK 500 THR B 135 56.45 -173.95 REMARK 500 ALA B 185 -72.72 -47.53 REMARK 500 ASN B 203 74.15 36.53 REMARK 500 ASP B 266 1.35 -61.32 REMARK 500 VAL B 269 115.09 -38.47 REMARK 500 GLN B 285 1.18 -66.09 REMARK 500 GLU B 327 143.19 -36.27 REMARK 500 PHE B 337 10.69 -67.19 REMARK 500 REMARK 500 THIS ENTRY HAS 62 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR A 607 PRO A 608 36.08 REMARK 500 PRO B 275 ASN B 276 -134.62 REMARK 500 GLY B 409 LEU B 410 -122.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 361 NE2 REMARK 620 2 HIS A 365 NE2 101.3 REMARK 620 3 GLU A 389 OE1 103.4 92.1 REMARK 620 4 HOH A2011 O 111.1 119.9 125.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 361 NE2 REMARK 620 2 HIS B 365 NE2 97.8 REMARK 620 3 GLU B 389 OE1 98.7 92.8 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C6N RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N REMARK 900 DOMAIN WITH LISINOPRIL DBREF 2C6F A 1 612 UNP P12821 ACE_HUMAN 30 641 DBREF 2C6F B 1 612 UNP P12821 ACE_HUMAN 30 641 SEQRES 1 A 612 LEU ASP PRO GLY LEU GLN PRO GLY ASN PHE SER ALA ASP SEQRES 2 A 612 GLU ALA GLY ALA GLN LEU PHE ALA GLN SER TYR ASN SER SEQRES 3 A 612 SER ALA GLU GLN VAL LEU PHE GLN SER VAL ALA ALA SER SEQRES 4 A 612 TRP ALA HIS ASP THR ASN ILE THR ALA GLU ASN ALA ARG SEQRES 5 A 612 ARG GLN GLU GLU ALA ALA LEU LEU SER GLN GLU PHE ALA SEQRES 6 A 612 GLU ALA TRP GLY GLN LYS ALA LYS GLU LEU TYR GLU PRO SEQRES 7 A 612 ILE TRP GLN ASN PHE THR ASP PRO GLN LEU ARG ARG ILE SEQRES 8 A 612 ILE GLY ALA VAL ARG THR LEU GLY SER ALA ASN LEU PRO SEQRES 9 A 612 LEU ALA LYS ARG GLN GLN TYR ASN ALA LEU LEU SER ASN SEQRES 10 A 612 MET SER ARG ILE TYR SER THR ALA LYS VAL CYS LEU PRO SEQRES 11 A 612 ASN LYS THR ALA THR CYS TRP SER LEU ASP PRO ASP LEU SEQRES 12 A 612 THR ASN ILE LEU ALA SER SER ARG SER TYR ALA MET LEU SEQRES 13 A 612 LEU PHE ALA TRP GLU GLY TRP HIS ASN ALA ALA GLY ILE SEQRES 14 A 612 PRO LEU LYS PRO LEU TYR GLU ASP PHE THR ALA LEU SER SEQRES 15 A 612 ASN GLU ALA TYR LYS GLN ASP GLY PHE THR ASP THR GLY SEQRES 16 A 612 ALA TYR TRP ARG SER TRP TYR ASN SER PRO THR PHE GLU SEQRES 17 A 612 ASP ASP LEU GLU HIS LEU TYR GLN GLN LEU GLU PRO LEU SEQRES 18 A 612 TYR LEU ASN LEU HIS ALA PHE VAL ARG ARG ALA LEU HIS SEQRES 19 A 612 ARG ARG TYR GLY ASP ARG TYR ILE ASN LEU ARG GLY PRO SEQRES 20 A 612 ILE PRO ALA HIS LEU LEU GLY ASP MET TRP ALA GLN SER SEQRES 21 A 612 TRP GLU ASN ILE TYR ASP MET VAL VAL PRO PHE PRO ASP SEQRES 22 A 612 LYS PRO ASN LEU ASP VAL THR SER THR MET LEU GLN GLN SEQRES 23 A 612 GLY TRP ASN ALA THR HIS MET PHE ARG VAL ALA GLU GLU SEQRES 24 A 612 PHE PHE THR SER LEU GLU LEU SER PRO MET PRO PRO GLU SEQRES 25 A 612 PHE TRP GLU GLY SER MET LEU GLU LYS PRO ALA ASP GLY SEQRES 26 A 612 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 27 A 612 ASN ARG LYS ASP PHE ARG ILE LYS GLN CYS THR ARG VAL SEQRES 28 A 612 THR MET ASP GLN LEU SER THR VAL HIS HIS GLU MET GLY SEQRES 29 A 612 HIS ILE GLN TYR TYR LEU GLN TYR LYS ASP LEU PRO VAL SEQRES 30 A 612 SER LEU ARG ARG GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 31 A 612 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO GLU SEQRES 32 A 612 HIS LEU HIS LYS ILE GLY LEU LEU ASP ARG VAL THR ASN SEQRES 33 A 612 ASP THR GLU SER ASP ILE ASN TYR LEU LEU LYS MET ALA SEQRES 34 A 612 LEU GLU LYS ILE ALA PHE LEU PRO PHE GLY TYR LEU VAL SEQRES 35 A 612 ASP GLN TRP ARG TRP GLY VAL PHE SER GLY ARG THR PRO SEQRES 36 A 612 PRO SER ARG TYR ASN PHE ASP TRP TRP TYR LEU ARG THR SEQRES 37 A 612 LYS TYR GLN GLY ILE CYS PRO PRO VAL THR ARG ASN GLU SEQRES 38 A 612 THR HIS PHE ASP ALA GLY ALA LYS PHE HIS VAL PRO ASN SEQRES 39 A 612 VAL THR PRO TYR ILE ARG TYR PHE VAL SER PHE VAL LEU SEQRES 40 A 612 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS GLU ALA GLY SEQRES 41 A 612 TYR GLU GLY PRO LEU HIS GLN CYS ASP ILE TYR ARG SER SEQRES 42 A 612 THR LYS ALA GLY ALA LYS LEU ARG LYS VAL LEU GLN ALA SEQRES 43 A 612 GLY SER SER ARG PRO TRP GLN GLU VAL LEU LYS ASP MET SEQRES 44 A 612 VAL GLY LEU ASP ALA LEU ASP ALA GLN PRO LEU LEU LYS SEQRES 45 A 612 TYR PHE GLN PRO VAL THR GLN TRP LEU GLN GLU GLN ASN SEQRES 46 A 612 GLN GLN ASN GLY GLU VAL LEU GLY TRP PRO GLU TYR GLN SEQRES 47 A 612 TRP HIS PRO PRO LEU PRO ASP ASN TYR PRO GLU GLY ILE SEQRES 48 A 612 ASP SEQRES 1 B 612 LEU ASP PRO GLY LEU GLN PRO GLY ASN PHE SER ALA ASP SEQRES 2 B 612 GLU ALA GLY ALA GLN LEU PHE ALA GLN SER TYR ASN SER SEQRES 3 B 612 SER ALA GLU GLN VAL LEU PHE GLN SER VAL ALA ALA SER SEQRES 4 B 612 TRP ALA HIS ASP THR ASN ILE THR ALA GLU ASN ALA ARG SEQRES 5 B 612 ARG GLN GLU GLU ALA ALA LEU LEU SER GLN GLU PHE ALA SEQRES 6 B 612 GLU ALA TRP GLY GLN LYS ALA LYS GLU LEU TYR GLU PRO SEQRES 7 B 612 ILE TRP GLN ASN PHE THR ASP PRO GLN LEU ARG ARG ILE SEQRES 8 B 612 ILE GLY ALA VAL ARG THR LEU GLY SER ALA ASN LEU PRO SEQRES 9 B 612 LEU ALA LYS ARG GLN GLN TYR ASN ALA LEU LEU SER ASN SEQRES 10 B 612 MET SER ARG ILE TYR SER THR ALA LYS VAL CYS LEU PRO SEQRES 11 B 612 ASN LYS THR ALA THR CYS TRP SER LEU ASP PRO ASP LEU SEQRES 12 B 612 THR ASN ILE LEU ALA SER SER ARG SER TYR ALA MET LEU SEQRES 13 B 612 LEU PHE ALA TRP GLU GLY TRP HIS ASN ALA ALA GLY ILE SEQRES 14 B 612 PRO LEU LYS PRO LEU TYR GLU ASP PHE THR ALA LEU SER SEQRES 15 B 612 ASN GLU ALA TYR LYS GLN ASP GLY PHE THR ASP THR GLY SEQRES 16 B 612 ALA TYR TRP ARG SER TRP TYR ASN SER PRO THR PHE GLU SEQRES 17 B 612 ASP ASP LEU GLU HIS LEU TYR GLN GLN LEU GLU PRO LEU SEQRES 18 B 612 TYR LEU ASN LEU HIS ALA PHE VAL ARG ARG ALA LEU HIS SEQRES 19 B 612 ARG ARG TYR GLY ASP ARG TYR ILE ASN LEU ARG GLY PRO SEQRES 20 B 612 ILE PRO ALA HIS LEU LEU GLY ASP MET TRP ALA GLN SER SEQRES 21 B 612 TRP GLU ASN ILE TYR ASP MET VAL VAL PRO PHE PRO ASP SEQRES 22 B 612 LYS PRO ASN LEU ASP VAL THR SER THR MET LEU GLN GLN SEQRES 23 B 612 GLY TRP ASN ALA THR HIS MET PHE ARG VAL ALA GLU GLU SEQRES 24 B 612 PHE PHE THR SER LEU GLU LEU SER PRO MET PRO PRO GLU SEQRES 25 B 612 PHE TRP GLU GLY SER MET LEU GLU LYS PRO ALA ASP GLY SEQRES 26 B 612 ARG GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR SEQRES 27 B 612 ASN ARG LYS ASP PHE ARG ILE LYS GLN CYS THR ARG VAL SEQRES 28 B 612 THR MET ASP GLN LEU SER THR VAL HIS HIS GLU MET GLY SEQRES 29 B 612 HIS ILE GLN TYR TYR LEU GLN TYR LYS ASP LEU PRO VAL SEQRES 30 B 612 SER LEU ARG ARG GLY ALA ASN PRO GLY PHE HIS GLU ALA SEQRES 31 B 612 ILE GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO GLU SEQRES 32 B 612 HIS LEU HIS LYS ILE GLY LEU LEU ASP ARG VAL THR ASN SEQRES 33 B 612 ASP THR GLU SER ASP ILE ASN TYR LEU LEU LYS MET ALA SEQRES 34 B 612 LEU GLU LYS ILE ALA PHE LEU PRO PHE GLY TYR LEU VAL SEQRES 35 B 612 ASP GLN TRP ARG TRP GLY VAL PHE SER GLY ARG THR PRO SEQRES 36 B 612 PRO SER ARG TYR ASN PHE ASP TRP TRP TYR LEU ARG THR SEQRES 37 B 612 LYS TYR GLN GLY ILE CYS PRO PRO VAL THR ARG ASN GLU SEQRES 38 B 612 THR HIS PHE ASP ALA GLY ALA LYS PHE HIS VAL PRO ASN SEQRES 39 B 612 VAL THR PRO TYR ILE ARG TYR PHE VAL SER PHE VAL LEU SEQRES 40 B 612 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS GLU ALA GLY SEQRES 41 B 612 TYR GLU GLY PRO LEU HIS GLN CYS ASP ILE TYR ARG SER SEQRES 42 B 612 THR LYS ALA GLY ALA LYS LEU ARG LYS VAL LEU GLN ALA SEQRES 43 B 612 GLY SER SER ARG PRO TRP GLN GLU VAL LEU LYS ASP MET SEQRES 44 B 612 VAL GLY LEU ASP ALA LEU ASP ALA GLN PRO LEU LEU LYS SEQRES 45 B 612 TYR PHE GLN PRO VAL THR GLN TRP LEU GLN GLU GLN ASN SEQRES 46 B 612 GLN GLN ASN GLY GLU VAL LEU GLY TRP PRO GLU TYR GLN SEQRES 47 B 612 TRP HIS PRO PRO LEU PRO ASP ASN TYR PRO GLU GLY ILE SEQRES 48 B 612 ASP MODRES 2C6F ASN A 25 ASN GLYCOSYLATION SITE MODRES 2C6F ASN A 45 ASN GLYCOSYLATION SITE MODRES 2C6F ASN A 117 ASN GLYCOSYLATION SITE MODRES 2C6F ASN A 289 ASN GLYCOSYLATION SITE MODRES 2C6F ASN A 480 ASN GLYCOSYLATION SITE MODRES 2C6F ASN B 25 ASN GLYCOSYLATION SITE MODRES 2C6F ASN B 45 ASN GLYCOSYLATION SITE MODRES 2C6F ASN B 117 ASN GLYCOSYLATION SITE MODRES 2C6F ASN B 480 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET NAG A 692 14 HET NAG A 695 14 HET NAG A 697 14 HET ZN A 701 1 HET CL A 702 1 HET ACT A 800 4 HET ACT A 801 4 HET GOL A2434 6 HET NAG B 692 14 HET NAG B 695 14 HET ZN B 701 1 HET CL B 703 1 HET ACT B 801 4 HET GOL B2433 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 13(C8 H15 N O6) FORMUL 10 ZN 2(ZN 2+) FORMUL 11 CL 2(CL 1-) FORMUL 12 ACT 3(C2 H3 O2 1-) FORMUL 14 GOL 2(C3 H8 O3) FORMUL 21 HOH *24(H2 O) HELIX 1 1 ASP A 2 GLN A 6 5 5 HELIX 2 2 ASP A 13 THR A 44 1 32 HELIX 3 3 THR A 47 GLU A 77 1 31 HELIX 4 4 ASP A 85 ARG A 96 1 12 HELIX 5 5 LEU A 98 LEU A 103 5 6 HELIX 6 6 PRO A 104 ALA A 125 1 22 HELIX 7 7 PRO A 141 SER A 150 1 10 HELIX 8 8 SER A 152 GLN A 188 1 37 HELIX 9 9 ASP A 193 SER A 200 1 8 HELIX 10 10 TRP A 201 ASN A 203 5 3 HELIX 11 11 THR A 206 GLY A 238 1 33 HELIX 12 12 TRP A 261 ASN A 263 5 3 HELIX 13 13 ILE A 264 VAL A 269 1 6 HELIX 14 14 VAL A 279 GLY A 287 1 9 HELIX 15 15 ASN A 289 LEU A 304 1 16 HELIX 16 16 PRO A 310 SER A 317 1 8 HELIX 17 17 THR A 352 LYS A 373 1 22 HELIX 18 18 PRO A 376 ARG A 380 5 5 HELIX 19 19 ASN A 384 THR A 401 1 18 HELIX 20 20 ASP A 417 ILE A 433 1 17 HELIX 21 21 ALA A 434 SER A 451 1 18 HELIX 22 22 PRO A 455 SER A 457 5 3 HELIX 23 23 ARG A 458 GLY A 472 1 15 HELIX 24 24 PHE A 484 LYS A 489 5 6 HELIX 25 25 TYR A 498 GLY A 520 1 23 HELIX 26 26 PRO A 524 CYS A 528 5 5 HELIX 27 27 SER A 533 GLN A 545 1 13 HELIX 28 28 PRO A 551 GLY A 561 1 11 HELIX 29 29 ALA A 567 PHE A 574 1 8 HELIX 30 30 PHE A 574 ASN A 588 1 15 HELIX 31 31 GLU B 14 THR B 44 1 31 HELIX 32 32 ALA B 48 TYR B 76 1 29 HELIX 33 33 ASP B 85 ARG B 96 1 12 HELIX 34 34 LEU B 98 LEU B 103 5 6 HELIX 35 35 PRO B 104 SER B 123 1 20 HELIX 36 36 PRO B 141 SER B 150 1 10 HELIX 37 37 SER B 152 ILE B 169 1 18 HELIX 38 38 LEU B 171 GLN B 188 1 18 HELIX 39 39 ASP B 193 SER B 200 1 8 HELIX 40 40 TRP B 201 ASN B 203 5 3 HELIX 41 41 THR B 206 GLY B 238 1 33 HELIX 42 42 TRP B 261 VAL B 268 5 8 HELIX 43 43 VAL B 279 GLN B 285 1 7 HELIX 44 44 ASN B 289 LEU B 304 1 16 HELIX 45 45 PRO B 310 SER B 317 1 8 HELIX 46 46 THR B 352 TYR B 372 1 21 HELIX 47 47 PRO B 376 ARG B 380 5 5 HELIX 48 48 ASN B 384 THR B 401 1 18 HELIX 49 49 THR B 401 LYS B 407 1 7 HELIX 50 50 THR B 418 LYS B 432 1 15 HELIX 51 51 ALA B 434 SER B 451 1 18 HELIX 52 52 PRO B 455 TYR B 459 5 5 HELIX 53 53 ASN B 460 GLN B 471 1 12 HELIX 54 54 PHE B 484 LYS B 489 5 6 HELIX 55 55 TYR B 498 ALA B 519 1 22 HELIX 56 56 PRO B 524 CYS B 528 5 5 HELIX 57 57 SER B 533 GLN B 545 1 13 HELIX 58 58 PRO B 551 VAL B 560 1 10 HELIX 59 59 ALA B 567 GLY B 589 1 23 SHEET 1 AA 2 LYS A 126 VAL A 127 0 SHEET 2 AA 2 TRP A 137 SER A 138 -1 O TRP A 137 N VAL A 127 SHEET 1 AB 2 ILE A 248 PRO A 249 0 SHEET 2 AB 2 ILE A 473 CYS A 474 1 N CYS A 474 O ILE A 248 SHEET 1 AC 2 SER A 333 ASP A 336 0 SHEET 2 AC 2 PHE A 343 LYS A 346 -1 O ARG A 344 N TRP A 335 SHEET 1 BA 2 ILE B 248 PRO B 249 0 SHEET 2 BA 2 ILE B 473 CYS B 474 1 N CYS B 474 O ILE B 248 SHEET 1 BB 2 SER B 333 ASP B 336 0 SHEET 2 BB 2 PHE B 343 LYS B 346 -1 O ARG B 344 N TRP B 335 SSBOND 1 CYS A 128 CYS A 136 1555 1555 1.56 SSBOND 2 CYS A 330 CYS A 348 1555 1555 2.06 SSBOND 3 CYS A 516 CYS A 528 1555 1555 2.00 SSBOND 4 CYS B 128 CYS B 136 1555 1555 2.06 SSBOND 5 CYS B 330 CYS B 348 1555 1555 2.01 SSBOND 6 CYS B 516 CYS B 528 1555 1555 2.03 LINK ND2 ASN A 25 C1 NAG D 1 1555 1555 1.48 LINK ND2 ASN A 45 C1 NAG A 692 1555 1555 1.45 LINK ND2 ASN A 45 O5 NAG A 692 1555 1555 2.02 LINK ND2 ASN A 117 C1 NAG A 695 1555 1555 1.48 LINK ND2 ASN A 289 C1 NAG A 697 1555 1555 1.47 LINK ND2 ASN A 289 O5 NAG A 697 1555 1555 1.82 LINK ND2 ASN A 480 C1 NAG C 1 1555 1555 1.46 LINK OE2 GLU A 596 O7 NAG C 1 3554 1555 2.02 LINK ND2 ASN B 25 C1 NAG F 1 1555 1555 1.48 LINK ND2 ASN B 25 O5 NAG F 1 1555 1555 2.05 LINK ND2 ASN B 45 C1 NAG B 692 1555 1555 1.43 LINK ND2 ASN B 117 C1 NAG B 695 1555 1555 1.45 LINK ND2 ASN B 480 C1 NAG E 1 1555 1555 1.47 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.48 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.47 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.48 LINK NE2 HIS A 361 ZN ZN A 701 1555 1555 2.10 LINK NE2 HIS A 365 ZN ZN A 701 1555 1555 2.30 LINK OE1 GLU A 389 ZN ZN A 701 1555 1555 1.99 LINK ZN ZN A 701 O HOH A2011 1555 1555 2.64 LINK NE2 HIS B 361 ZN ZN B 701 1555 1555 2.12 LINK NE2 HIS B 365 ZN ZN B 701 1555 1555 2.17 LINK OE1 GLU B 389 ZN ZN B 701 1555 1555 1.82 CISPEP 1 ASP A 140 PRO A 141 0 10.03 CISPEP 2 ASP B 140 PRO B 141 0 -5.83 CRYST1 101.120 211.320 171.270 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009889 0.000000 0.000000 0.00000 SCALE2 0.000000 0.004732 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005839 0.00000 MTRIX1 1 0.006620 0.999960 -0.005230 -0.61786 1 MTRIX2 1 0.999890 -0.006690 -0.013180 -0.64509 1 MTRIX3 1 -0.013220 -0.005140 -0.999900 -128.55352 1